ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 7,500 shares of the stock in a transaction on Monday, September 8th. The shares were sold at an average price of $16.06, for a total value of $120,450.00. Following the transaction, the chief executive officer directly owned 79,500 shares of the company's stock, valued at approximately $1,276,770. This trade represents a 8.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
ReposiTrak Price Performance
Shares of NYSE:TRAK traded up $0.18 during trading on Monday, hitting $17.35. 66,649 shares of the company were exchanged, compared to its average volume of 50,897. The firm has a market cap of $317.16 million, a P/E ratio of 51.03 and a beta of 0.47. The firm's 50 day moving average is $17.54. ReposiTrak Inc. has a 52-week low of $15.12 and a 52-week high of $25.01. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01.
ReposiTrak Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, August 14th. Shareholders of record on Monday, June 30th were given a dividend of $0.0182 per share. The ex-dividend date was Monday, June 30th. This represents a $0.07 annualized dividend and a dividend yield of 0.4%. ReposiTrak's dividend payout ratio is currently 20.59%.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded ReposiTrak from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.
Check Out Our Latest Research Report on TRAK
Hedge Funds Weigh In On ReposiTrak
A number of hedge funds and other institutional investors have recently modified their holdings of TRAK. Ellsworth Advisors LLC boosted its stake in ReposiTrak by 10.6% in the first quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company's stock valued at $634,000 after acquiring an additional 2,997 shares in the last quarter. R Squared Ltd purchased a new position in shares of ReposiTrak during the second quarter worth $235,000. Ingalls & Snyder LLC raised its holdings in shares of ReposiTrak by 1.3% during the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company's stock worth $3,905,000 after purchasing an additional 2,554 shares during the last quarter. Los Angeles Capital Management LLC purchased a new position in shares of ReposiTrak during the second quarter worth $818,000. Finally, Prescott Group Capital Management L.L.C. raised its holdings in shares of ReposiTrak by 47.2% during the second quarter. Prescott Group Capital Management L.L.C. now owns 26,284 shares of the company's stock worth $516,000 after purchasing an additional 8,428 shares during the last quarter. 27.35% of the stock is currently owned by institutional investors.
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.